Favorable Outcomes in Elderly Patients Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma-Reference-Cited by-同舟云学术

Favorable Outcomes in Elderly Patients Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma

Published:2014-12 Issue:12 Volume:20 Page:2004-2009
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Dahi Parastoo B.,Tamari Roni,Devlin Sean M.,Maloy Molly,Bhatt Valkal,Scordo Michael,Goldberg Jenna,Zelenetz Andrew D.,Hamlin Paul A.,Matasar Matthew J.,Maragulia Jocelyn,Giralt Sergio A.,Perales Miguel-Angel,Moskowitz Craig H.,Sauter Craig S.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference35 articles.

1. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma;Philip;N Eng J Med,1995

2. High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial;Schouten;J Clin Oncol,2003

3. Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur;Geisler;Br J Haematol,2012

4. Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group;Geisler;Blood,2008

5. Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant human thrombopoietin improves platelet engraftment after autologous hematopoietic stem cell transplantation in patients with aggressive lymphoma;Transfusion and Apheresis Science;2024-10

2. Transplantation and Cellular Therapy for Older Adults—The MSK Approach;Current Hematologic Malignancy Reports;2024-02-09

3. Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma;Leukemia & Lymphoma;2023-09-10

4. Reduced intensity conditioning prior to autologous stem cell transplantation in elderly DLBCL patients;2023-08-22

5. Recombinant human thrombopoietin improves platelet engraftment after autologous hematopoietic stem cell transplantation in patients with aggressive lymphoma;2023-08-07